COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?

While a human challenge study holds the prospect of accelerating the development of a vaccine for the coronavirus SARS-CoV-2, it may be opposed due to risks of harm to participants and researchers. Given the increasing number of human deaths and severe disruption to lives worldwide, we argue that a...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaefer, G. Owen, Tam, Clarence C., Savulescu, Julian, Voo, Teck Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269942/
https://www.ncbi.nlm.nih.gov/pubmed/32540271
http://dx.doi.org/10.1016/j.vaccine.2020.06.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269942/
https://www.ncbi.nlm.nih.gov/pubmed/32540271
http://dx.doi.org/10.1016/j.vaccine.2020.06.007

Ejemplares similares